CMS delayed Medicare BALANCE for 2027 and extended the GLP‑1 Bridge

What happened

CMS changed its Medicare GLP-1 rollout on April 21, 2026. The agency said the Part D portion of the BALANCE Model would not begin in 2027 as planned. At the same time, it extended the separate Medicare GLP-1 Bridge through December 31, 2027. The Bridge was still scheduled to open July 1, 2026.

The announcement came one day after the application deadline for Part D plan sponsors. The original BALANCE design was voluntary and required applications representing at least 80% of the enrollment used in CMS's participation calculation. Its planned Medicare launch depended on reaching that critical mass.

KFF reported that there was not enough interest among Part D sponsors to proceed under the 2027 design. KFF also noted reports that major sponsors were reluctant to participate. CMS's public explanation emphasized a longer Bridge period, more utilization data to share with plans, and the possibility of implementing BALANCE in Part D later. CMS did not announce a new Medicare BALANCE start date.

The two programs use different structures. Under the planned BALANCE model, participating Part D sponsors would have covered model drugs under negotiated terms. The Bridge instead runs outside the usual Part D coverage and payment flow. CMS uses a central processor for prior authorization, claim decisions, and pharmacy payment, so a Part D sponsor does not have to opt in and does not bear the drug risk for an eligible Bridge claim.

For an eligible beneficiary, the Bridge carries a $50 copay for a monthly supply. That payment does not count toward true out-of-pocket costs, the Part D deductible does not apply, and the low-income subsidy does not reduce it. Clinical eligibility, listed products, and prior authorization still apply.

What it means

The April 21 event changed the route and timeline for the Medicare portion of the policy. Instead of moving from a six-month Bridge into Part D BALANCE on January 1, 2027, CMS kept the Bridge structure operating through the end of 2027. That preserved a temporary access path while CMS gathered information and reconsidered a later Part D model.

The change did not cancel the Medicaid side of BALANCE. State Medicaid agencies followed a separate application and launch schedule. Readers should also distinguish this dated restructuring story from the current Bridge instructions, which now govern eligibility, covered products, and claim processing.

What it does not mean

CMS did not create permanent Medicare coverage of medicines used only for weight management. The Bridge remains a demonstration with an end date, and the agency did not promise that Medicare BALANCE would start in 2028 or under the original terms.

The extension did not make every Part D enrollee eligible or place every GLP-1 product in the program. It also did not move the $50 copay into the normal Part D benefit. Beneficiaries still need to satisfy the Bridge rules and obtain approval through its process.